For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Visterra, Inc.

USPTO Granted Patents = 37

EPO Patents = 7

Trademarks = 7

Forward Citations = 82

Loading Chart...

Loading Chart...

32 inventors (with patents filed for the assignee):

Zachary Shriver (32 out of 85 patents)

Karthik Viswanathan (29 out of 40 patents)

Boopathy Ramakrishnan (21 out of 21 patents)

4. Gregory Babcock (21 out of 33 patents)

5. Andrew M Wollacott (18 out of 18 patents)

6. James R Myette (13 out of 28 patents)

7. Hedy Adari-Hall (8 out of 8 patents)

8. Brian Booth (7 out of 7 patents)

9. Luke Nathaniel Robinson (6 out of 8 patents)

10. Vidya Subramanian (5 out of 15 patents)

11. Sasisekharan Raguram (5 out of 5 patents)

12. Susan Sloan (4 out of 4 patents)

13. Obadiah Joseph Plante (4 out of 5 patents)

14. James C Delaney (3 out of 3 patents)

15. Lauren Olinski (3 out of 3 patents)

37 patents: Sort by Forward Citations

1. 12415865 - Antibody molecules to C5AR1 and uses thereof (2025-09-16),

2. 12338291 - Humanized antibody molecules to CD138 and uses thereof (2025-06-24),

3. 12297249 - Interleukin-2 agents and uses thereof (2025-05-13),

4. 12264203 - Humanized complement 5a receptor 1 antibodies and methods of use thereof (2025-04-01),

5. 12227587 - Humanized complement 5A receptor 1 antibodies and methods of use thereof (2025-02-18),

6. 12202885 - Formulations of antibody molecules to influenza virus (2025-01-21),

7. 12187807 - Antibody molecules to C5AR1 and uses thereof (2025-01-07),

8. 12098178 - Methods of using interleukin-2 agents (2024-09-24),

9. 12091451 - Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL) (2024-09-17),

10. 12084484 - Interleukin-2 agents and uses thereof (2024-09-10),

11. 12054539 - Antibody molecules to dengue virus and uses thereof (2024-08-06),

12. 12024552 - Ha binding agents (2024-07-02),

13. 11969476 - Antibody molecule-drug conjugates and uses thereof (2024-04-30),

14. 11945868 - Antibody molecules to CD138 and uses thereof (2024-04-02),

15. 11918651 - Formulations of antibody molecules to dengue virus (2024-03-05),

Visterra, Inc. is a leading biotechnology company specializing in the development of novel therapeutics for infectious diseases. With its proprietary Hierotope™ platform, Visterra leverages advanced computational and synthetic biology approaches to discover and design precision medicines. By combining deep therapeutic insights with innovative technologies, Visterra aims to make a significant impact in the field of infectious diseases and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

37 Patents

#34 in Waltham, MA

#523 in Massachusetts

#8,947 in US

#17,724 in the World

Waltham, MA, United States of America

Visterra, Inc.

Forward Citations = 82

32 inventors:

Zachary Shriver (32 out of 85 patents)

Karthik Viswanathan (29 out of 40 patents)

Boopathy Ramakrishnan (21 out of 21 patents)

4. Gregory Babcock (21 out of 33 patents)

5. Andrew M Wollacott (18 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…